Alex Santini–Market Access
With over 30 years of pharmaceutical experience, Alex has held numerous sales, marketing, and key account management positions. Prior to Averitas Health, Alex was an integral part of Bayer Healthcare, formerly Berlex Laboratories, as the Vice President of the Market Access Group. Critical components of his role included leveraging executive level business to business relationships with corporate customers, providing quantitative and qualitative analysis of national healthcare trends, and leading the development of strategies and plans for key customers to maximize opportunities for current and future business. In addition to his senior role as VP Market Access, Alex was on numerous key committees and teams – Executive Committee Member, Operations Committee Chairman, Executive Pricing Committee Chairman, Core Team member-Global Market Access, National Pharmaceutical Council (NPC) Board Member, Public Policy Advisory Council, and Diversity & Inclusion Council.
Alex was the go-to-person for managed markets at Berlex and Bayer, setting the strategic direction, establishing the appropriate infrastructure and deploying suitable resources, as well as creating a value system in order to achieve desired business results. Alex has successfully led acquisition and divestiture efforts, identified key market opportunities, spearheaded product launch teams and managed large commercial operation teams.
Alex started his career at Berlex Laboratories as a Sales Consultant for the Diagnostic Imaging division, utilizing his experience as a Radiology Technologist to help him drive sales and successfully launch the world’s first MRI Contrast Agent, Magnevist. Alex had and extremely successful career in Imaging, holding numerous Sales Management and Marketing positions within the group. He then went on to head up the National Healthcare Accounts which became the Market Access Group at Bayer. Here he gained substantial expertise in Managed Markets and overall Market Access expertise.